| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet Infectious Diseases 18 (3), 318-327, 2018 | 1417 | 2018 |
| Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients AJ Riquelme, MA Calvo, AM Guzmán, MS Depix, P García, C Pérez, ... Journal of clinical gastroenterology 36 (1), 41-43, 2003 | 205 | 2003 |
| Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey A Versporten, P Zarb, I Caniaux, MF Gros, N Drapier, M Miller, V Jarlier, ... The Lancet Global Health 6 (6), e619-e629, 2018 | 202 | 2018 |
| Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America E Rodríguez-Noriega, C Seas, M Guzman-Blanco, C Mejía, C Alvarez, ... International Journal of Infectious Diseases 14 (7), e560-e566, 2010 | 185 | 2010 |
| Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America M Guzmán-Blanco, C Mejía, R Isturiz, C Alvarez, L Bavestrello, E Gotuzzo, ... International journal of antimicrobial agents 34 (4), 304-308, 2009 | 151 | 2009 |
| Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review JA Labarca, RM Rabaggliati, FJ Radrigan, PP Rojas, CM Perez, ... Clinical infectious diseases 24 (2), 197-200, 1997 | 124 | 1997 |
| Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America JA Labarca, MJC Salles, C Seas, M Guzmán-Blanco Critical reviews in microbiology 42 (2), 276-292, 2016 | 107 | 2016 |
| Campylobacter upsaliensis: Another Pathogen for Consideration in the United States AL Jaime, S Joan, B Lee, S Nancy, MH Sydney, L Eleanor, R Roshan, ... Clinical Infectious Diseases 34 (11), e59-e60, 2002 | 98 | 2002 |
| Coagulase-negative staphylococci: clinical, microbiological and molecular features to predict true bacteraemia P García, R Benítez, M Lam, AM Salinas, H Wirth, C Espinoza, T Garay, ... Journal of medical microbiology 53 (1), 67-72, 2004 | 94 | 2004 |
| Outbreak of Stenotrophomonas maltophilia Bacteremia in Allogenic Bone Marrow Transplant Patients: Role of Severe Neutropenia and Mucositis JA Labarca, AL Leber, VL Kern, MC Territo, LE Brankovic, DA Bruckner, ... Clinical infectious diseases 30 (1), 195-197, 2000 | 87 | 2000 |
| Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America M Guzmán-Blanco, JA Labarca, MV Villegas, E Gotuzzo Brazilian Journal of Infectious Diseases 18 (4), 421-433, 2014 | 86 | 2014 |
| Multistate Nosocomial Outbreak of Ralstonia pickettii Colonization Associated with an Intrinsically Contaminated Respiratory Care Solution JA Labarca, WE Trick, CL Peterson, LA Carson, SC Holt, MJ Arduino, ... Clinical Infectious Diseases 29 (5), 1281-1286, 1999 | 85 | 1999 |
| Successful Treatment of Trypanosoma cruzi Encephalitis in a Patient with Hemophilia and AIDS A Solari, H Saavedra, C Sepúlveda, D Oddó, G Acuña, J Labarca, ... Clinical Infectious Diseases 16 (2), 255-259, 1993 | 68 | 1993 |
| A prospective cohort multicenter study of molecular epidemiology and phylogenomics of Staphylococcus aureus bacteremia in nine Latin American countries CA Arias, J Reyes, LP Carvajal, S Rincon, L Diaz, D Panesso, G Ibarra, ... Antimicrobial agents and chemotherapy 61 (10), 2017 | 64 | 2017 |
| Current status of carbapenemases in Latin America JJ Maya, SJ Ruiz, VM Blanco, E Gotuzzo, M Guzman-Blanco, J Labarca, ... Expert review of anti-infective therapy 11 (7), 657-667, 2013 | 50 | 2013 |
| KPC‐producing Klebsiella pneumoniae, finally targeting Turkey J Labarca, L Poirel, M Özdamar, S Turkoglü, E Hakko, P Nordmann New microbes and new infections 2 (2), 50-51, 2014 | 40 | 2014 |
| Latin America Working Group on Bacterial Resistance. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America M Guzmán-Blanco, JA Labarca, MV Villegas, E Gotuzzo Braz J Infect Dis 18 (4), 421-33, 2014 | 38 | 2014 |
| Quinolonas: Aspectos generales sobre su estructura y clasificación S Mella, G ACUÑA, C PEREZ, J LABARCA, G GONZALEZ, H BELLO, ... Revista chilena de infectología 17 (1), 53-66, 2000 | 32 | 2000 |
| Heparin-induced transaminase elevations: a prospective study. A Guevara, J Labarca, G Gonzalez-Martin International journal of clinical pharmacology, therapy, and toxicology 31 …, 1993 | 32 | 1993 |
| Pandemic (H1N1) 2009 reinfection, chile CM Perez, M Ferres, JA Labarca Emerging Infectious Diseases 16 (1), 156, 2010 | 30 | 2010 |
